Remove 2010 Remove Food and Drug Administration Remove Leads Remove Physicians
article thumbnail

Beyond overall survival: Time to agree on the value of alternative oncology endpoints?

Clarivate

Furthermore, OS does not capture the broader priorities of patients and physicians; for example, when quality of life is a priority over prolonging survival [2]. Food and Drug Administration review process: clinical trial endpoints in oncology. Oncologist, 2010. Am J Cancer Res, 2021. 1121-1131. [2] 2] Cimen, A.,